🍽️ Akkermansia muciniphila (probiotic)

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations    |     πŸ“ Dosage Seen

Data Contradictions β€” Limits of Certainity

Impacted of Akkermansia muciniphila (probiotic) On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by Akkermansia muciniphila (probiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Akkermansiaceae family Increases 👪 Source Study
Akkermansiaceae family Increases 👪 Source Study
Akkermansiaceae family Increases 👪 Source Study
Akkermansia genus Increases 👪 Source Study
Akkermansia genus Increases 👪 Source Study
Akkermansia genus Increases 👪 Source Study
Akkermansia genus Increases 📓 Source Study
Akkermansia genus Increases 📓 Source Study
Akkermansia genus Increases 📓 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Akkermansia no rank Increases 👶 Source Study
unclassified Akkermansia no rank Increases 👶 Source Study
unclassified Akkermansia no rank Increases 👶 Source Study
Akkermansia glycaniphila species Increases 👶 Source Study
Akkermansia glycaniphila species Increases 👶 Source Study
Akkermansia glycaniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 👶 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Akkermansia muciniphila species Increases 📓 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Akkermansia muciniphila ATCC BAA-835 strain Increases 👶 Source Study
Chlamydiae/Verrucomicrobia group superphylum Increases ⚗️ Source Study

Impact of Akkermansia muciniphila (probiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Allergies 0.4 0.4
Alzheimer's disease 0.4 -0.4
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.4 0.8 -1
Asthma 0.8 0.8
Atherosclerosis 0.4 0.4
Autism 0.8 0.8 0
Celiac Disease 0.4 0.4
Cerebral Palsy 0.4 -0.4
Chronic Urticaria (Hives) 0.4 0.4
COVID-19 0.8 0.4 1
Crohn's Disease 0.4 0.4 0
Depression 0.8 0.8 0
Epilepsy 0.8 0.4 1
Hashimoto's thyroiditis 0.4 -0.4
hypercholesterolemia (High Cholesterol) 0.4 0.4
hyperglycemia 0.8 0.3 1.67
Hyperlipidemia (High Blood Fats) 0.4 -0.4
hypertension (High Blood Pressure 0.4 0.4 0
Hypoxia 0.4 -0.4
Inflammatory Bowel Disease 0.8 0.8
Irritable Bowel Syndrome 0.4 0.4 0
Liver Cirrhosis 0.4 0.4 0
Long COVID 0.4 -0.4
Lung Cancer 0.4 0.4
Metabolic Syndrome 0.8 0.4 1
Mood Disorders 0.8 1.1 -0.38
multiple chemical sensitivity [MCS] 0.4 -0.4
Multiple Sclerosis 0.8 -0.8
Multiple system atrophy (MSA) 0.8 -0.8
Neuropathy (all types) 0.4 -0.4
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.4 0.4
Obesity 0.8 0.8 0
obsessive-compulsive disorder 0.4 0.4
Osteoporosis 0.4 0.4
Parkinson's Disease 1.1 -1.1
Polycystic ovary syndrome 0.4 0.4
Psoriasis 0.4 0.4 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.4 -0.4
Schizophrenia 0.4 -0.4
Stress / posttraumatic stress disorder 0.4 0.4 0
Tourette syndrome 0.4 -0.4
Type 2 Diabetes 0.8 0.4 1
Ulcerative colitis 0.8 0.8
Unhealthy Ageing 0.4 0.4

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)